Stoke Therapeutics, Inc. (STOK)
33.51
+0.32
(+0.96%)
USD |
NASDAQ |
Mar 20, 16:00
33.66
+0.15
(+0.45%)
After-Hours: 20:00
Stoke Therapeutics Research and Development Expense (Quarterly) : 41.29M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Biogen, Inc. | 434.00M |
| Krystal Biotech, Inc. | 13.23M |
| Scholar Rock Holding Corp. | 46.45M |
| Vertex Pharmaceuticals, Inc. | 973.70M |
| Zymeworks, Inc. | 31.24M |